Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ENOV | FTK |
|---|---|---|
| Price | $17.61 | $28.06 |
| Change today | ▼ 3.24% | ▼ 6.37% |
| Market cap | $1.02B | $1.02B |
| Return, 3 months | -30.2% | +12.6% |
| Return, year to date | -33.9% | +62.9% |
| Return, 1 year | -44.6% | +71.7% |
| P/E (TTM) | -0.9 | 27.8 |
| P/B | 0.7 | 7.9 |
| P/E percentile vs own 5y | 72nd | 76th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +3.2% | +70.3% |
| Net profit growth (YoY) | +97.2% | +463.0% |
| Gross margin | 61.1% | 24.7% |
| Operating margin | 3.1% | 13.1% |
| Net margin | -48.0% | 13.0% |
| Return on equity | -54.3% | 37.8% |
| Analyst target vs. price | +116.8% | +35.8% |
| Analyst buy share | 92% | 100% |
| RSI (14) | 37 | 48 |
| 30-day volatility | 70.2% | 64.8% |
| Max drawdown, 1 year | -46.4% | -41.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
